Loading…
avatar for Kurt von Emster

Kurt von Emster

Abingworth
Managing Partner
Kurt joined Abingworth in 2015 and was promoted to Managing Partner shortly thereafter. He currently holds board positions at CRISPR Therapeutics, SutroVax and CymaBay. Kurt began his career as a Biotechnology and Healthcare Analyst and Portfolio Manager at Franklin Templeton in 1990 before becoming a General Partner at MPM Capital in 2001. In 2009, he co-founded venBio, a US healthcare investment firm and was a Partner in the San Francisco office.

My Speakers Sessions

Wednesday, June 21
 

10:30am CDT